Bharat Biotech assures safety of Covaxin.

Indian vaccine maker Bharat Biotech, developer of Covaxin, asserts its focus on safety amid reports of rare side effects from AstraZeneca's COVID-19 vaccine. Covaxin, the only Indian vaccine in the country's immunization program, has demonstrated an excellent safety record, and Bharat Biotech emphasizes its commitment to prioritizing safety in all its vaccines. No reports of vaccine-associated incidents have been reported with Covaxin.

May 02, 2024
3 Articles